Prochloraz

Prochloraz

SCHEMBL6620360

CCCN(CCOc1c(Cl)cc(Cl)cc1Cl)C(=O)n1ccnc1.Nc1ccc(Br)cc1[N+](=O)[O-]

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.69
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
S1PR4 O95977 1/20 0.33
TSPO P30536 1/20 0.33
LMNA P02545 2/20 0.32
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
ADRB3 P13945 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 2/20 0.31
PKM P14618 2/20 0.31
MAPK1 P28482 2/20 0.31
THRB P10828 1/20 0.31
GLA P06280 1/20 0.31
POLB P06746 1/20 0.31
HPGD P15428 1/20 0.31
CTDSP1 Q9GZU7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Prochloraz SCHEMBL11376321 0.85 AHR (0.88) AHRMEN1KMT2AALDH1A1MAPT
Prochloraz SCHEMBL34675 0.83 AHR (1.00) AHRMEN1KMT2AMAPTLMNA
Prochloraz SCHEMBL22242 0.83 AHR (1.00) AHRMEN1KMT2AMAPTLMNA
Prochloraz SCHEMBL9371936 0.82 AHR (0.98) AHRMEN1KMT2AMAPTLMNA
Prochloraz SCHEMBL11379280 0.82 AHR (0.98) AHRMEN1KMT2AMAPTLMNA
Prochloraz SCHEMBL12611119 0.82 AHR (0.98) AHRMEN1KMT2AMAPTLMNA
Prochloraz SCHEMBL5454581 0.82 AHR (0.98) AHRMEN1KMT2AMAPTLMNA
Prochloraz SCHEMBL10346525 0.82 AHR (0.98) AHRMEN1KMT2AMAPTLMNA
Prochloraz SCHEMBL11375792 0.82 AHR (0.98) AHRMEN1KMT2AMAPTLMNA
Prochloraz SCHEMBL11376171 0.82 AHR (0.98) AHRMEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1196412-B1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-06-09 EP disclosed
US-6716841-B2 SUCH AS 1-((1-(3-(AMINOMETHYL)PHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-YL)CARBONYL) -5-(2-( AMINOSULFONYL)PHENYL)-2,3-DIHYDRO-1H-INDOLE FOR TREATMENT AND PREVENTION OF THROMBOEMBOLIC DISORDERS; ANTICOAGULANTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-04-06 US disclosed
US-20030096820-A1 Nitrogen containing heterobicycles as factor Xa inhibitors JACOBSON IRINA C (US) 2003-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096820-A1 Nitrogen containing heterobicycles as factor Xa inhibitors SERPINC1, CTRB1, F2 AHR 2993/4885MEN1 829/4885KMT2A 3995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.